跳至主要内容
临床试验/NCT05578261
NCT05578261进行中(未招募)不适用

Explore the Impacts of One Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder

Chang Gung Memorial Hospital1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2022年12月28日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
10
试验地点
1
主要终点
Adverse effects report form (Tinnitus)

研究概览

简要总结

The investigator would like to investigate the impact of theta-burst stimulation over cerebellum in adults with autism spectrum disorder

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with autism spectrum disorder (≥18 years old), confirmed by Autism Diagnostic Observation Schedule.

排除标准

  • Previous or current severe neurological disorder such as epilepsy, visual or hearing impairment.
  • Previous or current severe systemic disease such as cardiovascular disease, diabetes or infection.
  • Previous or current severe brain injury
  • Implementation of metal materials such as pacemaker or medication pump
  • Previous or current severe psychiatric disorders such as schizophrenia, bipolar disorder or substance abuse
  • Pregnancy
  • Individuals with a significant brain abnormality such as intracranial space occupied lesions
  • History of brain surgery or nervous system infection, such as meningitis and encephalitis
  • Concurrent use of medications which increased the risk of seizure attack
  • Participate another clinical trial within one month
  • Skin trauma on application site
  • Individuals suffering from multiple sclerosis
  • Individuals with a large ischemic scar
  • Individuals suffering from sleep deprivation during rTMS procedures
  • Individuals with a heavy consumption of alcohol
  • Current taking antiepileptic drugs
  • Individuals with a migraine headache from increased intracranial pressure
  • Unable to complete MRI scan
  • Withdrawal criteria:
  • Seizure attack during study period
  • Autistic symptoms worsened obviously during study period
  • Extreme agitation or irritability during study period
  • Participants request
  • Take antiepileptic drug during study period

结局指标

主要结局

Adverse effects report form (Tinnitus)

时间窗: 1 week after iTBS (post iTBS)

Recording adverse effects in participants after iTBS.

Adverse effects report form (Seizure)

时间窗: 1 week after iTBS (post iTBS)

Recording adverse effects in participants after iTBS.

Adverse effects report form (Headache)

时间窗: 1 week after iTBS (post iTBS)

Recording adverse effects in participants after iTBS.

Adverse effects report form (Other)

时间窗: 1 week after iTBS (post iTBS)

Recording adverse effects in participants after iTBS.

Adverse effects report form (Dizziness)

时间窗: 1 week after iTBS (post iTBS)

Recording adverse effects in participants after iTBS.

次要结局

  • MRI T1(Within one month)
  • functional MRI (resting-state/biological motion task) - BOLD signal(Within one month)

研究者

发起方
Chang Gung Memorial Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验